Home

Programm Hauptquartier Unterscheidung capsid assembly modulator leeren Heroin Wunde

Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel  Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects |  SpringerLink
Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects | SpringerLink

JCM | Free Full-Text | Capsid Assembly Modulators as Antiviral Agents  against HBV: Molecular Mechanisms and Clinical Perspectives
JCM | Free Full-Text | Capsid Assembly Modulators as Antiviral Agents against HBV: Molecular Mechanisms and Clinical Perspectives

Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human  Hepatocytes Infected with Hepatitis B Virus | Antimicrobial Agents and  Chemotherapy
Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus | Antimicrobial Agents and Chemotherapy

The SAR-based development of small molecular HBV capsid assembly modulators  | SpringerLink
The SAR-based development of small molecular HBV capsid assembly modulators | SpringerLink

An Oral Hepatitis B Virus Capsid Inhibitor - Protheragen
An Oral Hepatitis B Virus Capsid Inhibitor - Protheragen

Effect of JNJ-827 and JNJ-890 on capsid assembly in tubo and in... |  Download Scientific Diagram
Effect of JNJ-827 and JNJ-890 on capsid assembly in tubo and in... | Download Scientific Diagram

Recent advances in the development of HBV capsid assembly modulators -  ScienceDirect
Recent advances in the development of HBV capsid assembly modulators - ScienceDirect

Pharmaceuticals | Free Full-Text | Design and Synthesis of Hepatitis B  Virus (HBV) Capsid Assembly Modulators and Evaluation of Their Activity in  Mammalian Cell Model
Pharmaceuticals | Free Full-Text | Design and Synthesis of Hepatitis B Virus (HBV) Capsid Assembly Modulators and Evaluation of Their Activity in Mammalian Cell Model

Discovery of novel HBV capsid assembly modulator with broad-spectrum  anti-HBV activity | BioWorld
Discovery of novel HBV capsid assembly modulator with broad-spectrum anti-HBV activity | BioWorld

Potent non-HAP class I HBV capsid assembly modulator ALG-005398 reduces  HBsAg levels in vivo | 2021-11-22 | BioWorld
Potent non-HAP class I HBV capsid assembly modulator ALG-005398 reduces HBsAg levels in vivo | 2021-11-22 | BioWorld

Current and future directions for the management of hepatitis B
Current and future directions for the management of hepatitis B

GLP-26 is a HBV Capsid Assembly Modulator - Immune System Research
GLP-26 is a HBV Capsid Assembly Modulator - Immune System Research

Nomenclature of HBV core protein-targeting antivirals | Nature Reviews  Gastroenterology & Hepatology
Nomenclature of HBV core protein-targeting antivirals | Nature Reviews Gastroenterology & Hepatology

HBV capsid assembly modulators induce formation of capsid-like or... |  Download Scientific Diagram
HBV capsid assembly modulators induce formation of capsid-like or... | Download Scientific Diagram

Modulators of HBV capsid assembly as an approach to treating hepatitis B  virus infection - ScienceDirect
Modulators of HBV capsid assembly as an approach to treating hepatitis B virus infection - ScienceDirect

Safety, Pharmacokinetics and Antiviral Activity of Novel HBV Capsid  Assembly Modulator, JNJ-56136379, in Patients with Chronic Hepatitis B
Safety, Pharmacokinetics and Antiviral Activity of Novel HBV Capsid Assembly Modulator, JNJ-56136379, in Patients with Chronic Hepatitis B

HBV core protein allosteric modulators differentially alter cccDNA  biosynthesis from de novo infection and intracellular amplification  pathways | PLOS Pathogens
HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways | PLOS Pathogens

JCM | Free Full-Text | Capsid Assembly Modulators as Antiviral Agents  against HBV: Molecular Mechanisms and Clinical Perspectives
JCM | Free Full-Text | Capsid Assembly Modulators as Antiviral Agents against HBV: Molecular Mechanisms and Clinical Perspectives

Safety, Pharmacokinetics and Antiviral Activity of Novel HBV Capsid  Assembly Modulator, JNJ-56136379, in Patients with Chronic Hepatitis B
Safety, Pharmacokinetics and Antiviral Activity of Novel HBV Capsid Assembly Modulator, JNJ-56136379, in Patients with Chronic Hepatitis B

PDF) HBV Capsid Assembly Modulators, but not Nucleoside Analogs, Inhibit  the Production of Extracellular Pregenomic RNA and Spliced RNA Variants
PDF) HBV Capsid Assembly Modulators, but not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants

Recent advances in the development of HBV capsid assembly modulators -  ScienceDirect
Recent advances in the development of HBV capsid assembly modulators - ScienceDirect

Structures of Hepatitis B Virus Core- and e-Antigen Immune Complexes  Suggest Multi-point Inhibition. - Abstract - Europe PMC
Structures of Hepatitis B Virus Core- and e-Antigen Immune Complexes Suggest Multi-point Inhibition. - Abstract - Europe PMC

Capsid assembly modulator JNJ-56136379 prevents de novo infection of  primary human hepatocytes with hepatitis B virus
Capsid assembly modulator JNJ-56136379 prevents de novo infection of primary human hepatocytes with hepatitis B virus